Benitec Biopharma Inc. (BNTC) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US08205P2092
Benitec Biopharma Inc. financials
| Fiscal year | 2025 | 2026 |
|---|---|---|
| Operating income | -41.77 m USD | -51.19 m USD |
| EBIT | -37.92 m USD | -45.55 m USD |
| Net income | -37.92 m USD | -45.55 m USD |
| Diluted EPS – continuing operations | -1.05 USD | -0.98 USD |
Full history since 2004, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Benitec Biopharma Inc.
Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. Its Silence and Replace, a DNA-directedRNA interference platform combines RNA interference with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The company is developing BB-301, an AAV-based gene therapy designed to silence the expression of the disease-causing gene for the treatment of oculopharyngeal muscular dystrophy related dysphagia. Benitec Biopharma Inc. is headquartered in Hayward, California.
More stocks
- Ideal Group S.A (INTEK.AT)
- Bank of Greece (TELL.AT)
- SuZhou ChunXing Precision Mechanical Co Ltd (002547.SZ)
- NOVAL PROPERTY REAL ESTATE INVE (NOVAL.AT)
- WEBRAY ORD A (SHH) EQSW Exp: (688651.SS)
- Villeroy & Boch (VIB3.DE)
- Kogeneracja SA (KGN.WA)
- Shih Her Technologies (3551.TWO)
- X4 Pharmaceuticals, Inc (XFOR)
- Universal Vision Biotechnology Co Ltd (3218.TWO)
- Guangdong Jushen Logistics Co Ltd (001202.SZ)
- Hangzhou Gisway Information Technology Co. Ltd. A (301390.SZ)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.